Ventricular tachycardia cardiac MRI: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
(→MRI) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
When [[structural heart disease]] is suspected in the context of ventricular tachycardia, it is necessary to have an accurate evaluation of the structure and function of the [[atria]] and [[ventricle]]s. While [[echocardiography]] is the first modality of choice, [[MRI]] is used when the assessment provided by [[echocardiography]] is not satisfactory. In addition, [[MRI]] seems to have an important role in the evaluation of suspected [[arrhythmogenic right ventricular cardiomyopathy]] because [[MRI]] provides a good assessment of the [[RV|right ventricular]] structure, function and fatty infiltration if present. | When [[structural heart disease]] is suspected in the context of ventricular tachycardia, it is necessary to have an accurate evaluation of the structure and function of the [[atria]] and [[ventricle]]s. While [[echocardiography]] is the first modality of choice, [[MRI]] is used when the assessment provided by [[echocardiography]] is not satisfactory. In addition, [[MRI]] seems to have an important role in the evaluation of suspected [[arrhythmogenic right ventricular cardiomyopathy]] because [[MRI]] provides a good assessment of the [[RV|right ventricular]] structure, function and fatty infiltration if present. | ||
==MRI== | == [[Cardiac MRI]]== | ||
* [[ Cardiac MRL]] is an accurate modality for evaluation of the following: | |||
# Quantification of [[LVEF]], [[left ventricular]] mass, and [[volume]] | |||
# Anomaly of [[coronary arteries]] origin | |||
# [[Valvular heart disease]] | |||
# [[Myocardial scar]] | |||
# [[Infiltrative process]] by late [[gadolinium]] enhancement | |||
# [[LV]] , [[RV]] function | |||
* Degree of fibrosis in [[LV]], [[RV]] in [[HCM]] and [[ ARVC]] | |||
*[[Cardiac magnetic resonance imaging]] can be especially helpful in the evaluation of uncommon [[myocardial]] infiltrative diseases, such as [[sarcoidosis]].<ref name="pmid16443541">{{cite journal| author=Kiès P, Bootsma M, Bax J, Schalij MJ, van der Wall EE| title=Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. | journal=Heart Rhythm | year= 2006 | volume= 3 | issue= 2 | pages= 225-34 | pmid=16443541 | doi=10.1016/j.hrthm.2005.10.018 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16443541 }} </ref><ref name="pmid16935995">{{cite journal| author=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al.| title=ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | journal=Circulation | year= 2006 | volume= 114 | issue= 10 | pages= e385-484 | pmid=16935995 | doi=10.1161/CIRCULATIONAHA.106.178233 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16935995}}</ref><ref name="pmid15364314">{{cite journal| author=Lima JA, Desai MY| title=Cardiovascular magnetic resonance imaging: current and emerging applications. | journal=J Am Coll Cardiol | year= 2004 | volume= 44 | issue= 6 | pages= 1164-71 | pmid=15364314 | doi=10.1016/j.jacc.2004.06.033 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15364314 }} </ref> | *[[Cardiac magnetic resonance imaging]] can be especially helpful in the evaluation of uncommon [[myocardial]] infiltrative diseases, such as [[sarcoidosis]].<ref name="pmid16443541">{{cite journal| author=Kiès P, Bootsma M, Bax J, Schalij MJ, van der Wall EE| title=Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. | journal=Heart Rhythm | year= 2006 | volume= 3 | issue= 2 | pages= 225-34 | pmid=16443541 | doi=10.1016/j.hrthm.2005.10.018 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16443541 }} </ref><ref name="pmid16935995">{{cite journal| author=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al.| title=ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | journal=Circulation | year= 2006 | volume= 114 | issue= 10 | pages= e385-484 | pmid=16935995 | doi=10.1161/CIRCULATIONAHA.106.178233 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16935995}}</ref><ref name="pmid15364314">{{cite journal| author=Lima JA, Desai MY| title=Cardiovascular magnetic resonance imaging: current and emerging applications. | journal=J Am Coll Cardiol | year= 2004 | volume= 44 | issue= 6 | pages= 1164-71 | pmid=15364314 | doi=10.1016/j.jacc.2004.06.033 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15364314 }} </ref> | ||
Revision as of 12:22, 9 May 2021
|
Ventricular tachycardia Microchapters |
|
Differentiating Ventricular Tachycardia from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Ventricular tachycardia cardiac MRI On the Web |
|
Risk calculators and risk factors for Ventricular tachycardia cardiac MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
When structural heart disease is suspected in the context of ventricular tachycardia, it is necessary to have an accurate evaluation of the structure and function of the atria and ventricles. While echocardiography is the first modality of choice, MRI is used when the assessment provided by echocardiography is not satisfactory. In addition, MRI seems to have an important role in the evaluation of suspected arrhythmogenic right ventricular cardiomyopathy because MRI provides a good assessment of the right ventricular structure, function and fatty infiltration if present.
Cardiac MRI
- Cardiac MRL is an accurate modality for evaluation of the following:
- Quantification of LVEF, left ventricular mass, and volume
- Anomaly of coronary arteries origin
- Valvular heart disease
- Myocardial scar
- Infiltrative process by late gadolinium enhancement
- LV , RV function
- Cardiac magnetic resonance imaging can be especially helpful in the evaluation of uncommon myocardial infiltrative diseases, such as sarcoidosis.[1][2][3]
- MRI can be useful in patients with ventricular tachycardia when echocardiography fails to provide accurate evaluation of left or right ventricular function.
2006 ACC/AHA/ESC Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT) [2]
Left Ventricular Function and Imaging (DO NOT EDIT) [2]
| Class IIa |
| "1. MRI, cardiac computed tomography (CT), or radionuclide angiography can be useful in patients with ventricular arrhythmias when echocardiography does not provide accurate assessment of LV and RV function and/or evaluation of structural changes. (Level of Evidence B)" |
| "2. LV imaging can be useful in patients undergoing biventricular pacing. (Level of Evidence C)" |
References
- ↑ Kiès P, Bootsma M, Bax J, Schalij MJ, van der Wall EE (2006). "Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment". Heart Rhythm. 3 (2): 225–34. doi:10.1016/j.hrthm.2005.10.018. PMID 16443541.
- ↑ 2.0 2.1 2.2 Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.
- ↑ Lima JA, Desai MY (2004). "Cardiovascular magnetic resonance imaging: current and emerging applications". J Am Coll Cardiol. 44 (6): 1164–71. doi:10.1016/j.jacc.2004.06.033. PMID 15364314.